SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-06-001670
Filing Date
2006-07-14
Accepted
2006-07-14 07:59:32
Documents
7
Period of Report
2006-04-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT peregrine_10k-043006.htm 10-K 1963515
2 FORM OF PERFORMANCE SHARE AWARD AGREEMENT / STOCK BONUS PLAN DATED FEBRUARY 13, peregrine_10kex10-106.htm EX-10.106 61180
3 SUBSIDIARIES OF REGISTRANT peregrine_10k-ex2100.htm EX-21 3355
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM peregrine_10k-ex2301.htm EX-23.1 3939
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES peregrine_10k-ex3101.htm EX-31.1 12772
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES peregrine_10k-ex3102.htm EX-31.2 13172
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO peregrine_10k-ex32.htm EX-32 12712
  Complete submission text file 0001019687-06-001670.txt   2072244
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-32839 | Film No.: 06961653
SIC: 2835 In Vitro & In Vivo Diagnostic Substances